ConductScience.org, home

Paper42909080PubMed

Trifunctional antibody fusion proteins for targeted co-delivery of 4-1BBL with IL-15 or IL-21 to enhance antitumor immune responses.

Möller AM and 5 others. Front Immunol, 2026.

Cite this record

ConductScience Library. Trifunctional antibody fusion proteins for targeted co-delivery of 4-1BBL with IL-15 or IL-21 to enhance antitumor immune responses. Papers, record 42909080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42909080

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Trifunctional antibody fusion proteins for targeted co-delivery of 4-1BBL with IL-15 or IL-21 to enhance antitumor immune responses.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-27

Source PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Möller AMAnnika M
2Baumann FFelix
3Pütter MMax
4Xie MMeng
5Löffler AKAnn-Kathrin
6Müller DDafne

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-15Major topic
Recombinant Fusion ProteinsMajor topic
InterleukinsMajor topic
4-1BB LigandMajor topic
NeoplasmsMajor topic
Humans
Interleukin-21
Cell Line, Tumor
Animals
Immunotherapy

Source PubMed

Download CSV of topics

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134064598CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development.Cancers (Basel)2021https://conductscience.org/library/papers/34064598PubMed
238739434IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion.Mol Cancer Ther2024https://conductscience.org/library/papers/38739434PubMed
327435400IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.Clin Cancer Res2017https://conductscience.org/library/papers/27435400PubMed
4295110664-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses.J Exp Med2018https://conductscience.org/library/papers/29511066PubMed
541283511CEA-4-1BBL: CEACAM5-Targeted 4-1BB Ligand Fusion Proteins for Cis Co-Stimulation with CEA-TCB.Antibodies (Basel)2025https://conductscience.org/library/papers/41283511PubMed
623715927Evaluating combinations of costimulatory antibody-ligand fusion proteins for targeted cancer immunotherapy.Cancer Immunol Immunother2013https://conductscience.org/library/papers/23715927PubMed
741800025Advances in IL-2 Family Cytokine-Based Cancer Therapies: Overcoming Challenges Through Molecular Engineering and Delivery Strategies.Immune Netw2026https://conductscience.org/library/papers/41800025PubMed
824198185Combining antibody-directed presentation of IL-15 and 4-1BBL in a trifunctional fusion protein for cancer immunotherapy.Mol Cancer Ther2014https://conductscience.org/library/papers/24198185PubMed
931189721Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy.Sci Transl Med2019https://conductscience.org/library/papers/31189721PubMed
1019383914Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.Cancer Res2009https://conductscience.org/library/papers/19383914PubMed
1112370353Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.J Immunol2002https://conductscience.org/library/papers/12370353PubMed
1236699615Expanded NK cells used for adoptive cell therapy maintain diverse clonality and contain long-lived memory-like NK cell populations.Mol Ther Oncolytics2023https://conductscience.org/library/papers/36699615PubMed
1318523273ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.J Immunol2008https://conductscience.org/library/papers/18523273PubMed
1432357256Expanded clinical-grade membrane-bound IL-21/4-1BBL NK cell products exhibit activity against acute myeloid leukemia in vivo.Eur J Immunol2020https://conductscience.org/library/papers/32357256PubMed
1527831501Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy.Ann Oncol2017https://conductscience.org/library/papers/27831501PubMed
1639475618Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments.Sci Adv2024https://conductscience.org/library/papers/39475618PubMed
1729866855Altered p53 functionality in cancer-associated fibroblasts contributes to their cancer-supporting features.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29866855PubMed
1841081911CAR NK cell production from human cord blood NK progenitor cells is enhanced by stimulation of the IL-15 receptor.Cancer Immunol Immunother2025https://conductscience.org/library/papers/41081911PubMed
1939373147Targeted therapy of multiple myeloma by IL21-NKG2D CAR-T cells.J Investig Med2025https://conductscience.org/library/papers/39373147PubMed
2036727218The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy.MAbs2023https://conductscience.org/library/papers/36727218PubMed

See all 57 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42909080

GET https://conductscience.org/api/papers/v1/42909080/references?page=2